SNShankar Prasad Nagaraju

Shankar Prasad Nagaraju

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shankar Prasad Nagaraju has a total of 155 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patterns of kidney supportive care referrals in a tertiary hospital in India: a six-year audit

    by S. Gayatri, Arun Ghoshal, Anuja Damani, Shreya Nair, Shailja Sharma, Trishtha Agarwal, Aahaan Agarwal, Krithika S. Rao, N. Shankar Prasad, Naveen Salins

    Background: Patients with end-stage kidney disease (ESKD) and acute kidney injury on chronic kidney disease (AKI-on-CKD) experience significant symptom burden and high mortality, yet evidence for structured palliative integration within nephrology remains limited in low- and middle-income countries. Aim: To describe the timing and reasons for referrals from Nephrology to Palliative Medicine, the interventions delivered, and clinical outcomes following referral. Methods: A retrospective cohort study was conducted of all adult patients ( n = 325) referred from Nephrology to Palliative Medicine. Data included demographics, renal diagnosis, dialysis modality, comorbidities, treatment intent, and documented palliative interventions, and were analyzed using descriptive statistics. Results: Mean age was 63.6 ± 14.1 years; 229 (70.5%) were male. Renal diagnoses comprised ESKD (215; 66.2%), AKI-on-CKD (86; 26.5%), and AKI (16; 4.9%). Dialysis modalities included maintenance hemodialysis (194, 59.7%), dialysis for AKI (63, 19.4%), and conservative kidney management (21, 6.5%). Referrals were primarily for GOC discussions (41.5%), followed by pain and symptom management (29.2%) and end-of-life (EOL) care (27.4%). Referrals specifically for conservative kidney management were uncommon (1.8%). Among deaths, 154 (75%) occurred in the hospital. Common triggers for referral included sepsis, multiorgan failure, and decisions to stop dialysis. Conclusion: Palliative care involvement predominantly occurred during acute decline—often related to sepsis, multiorgan failure, or dialysis withdrawal. Although most patients died in the hospital, the high frequency of GOC and EOL discussions highlights the need for earlier, proactive palliative care engagement to support informed decision-making, symptom relief, and care aligned with patient preferences.

  • Open Access

    Clinical Profile and Outcome of C3-Dominant Glomerulonephritis: Retrospective Study

    by Vishrut Khullar, Attur Ravindra Prabhu, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Indu Ramachandra Rao, Srinivas Vinayak Shenoy, Mohan V. Bhojaraja, Gaurvi Piplani, Mahesha Vankalakunti

    Background: Complement 3 (C3)-dominant glomerulonephritis (GN) are rare diseases resulting from alternative complement pathway dysregulation; they include C3 glomerulopathy (C3G), paraprotein-associated GN, and C3-dominant infection-related GN (IRGN). To our knowledge, long-term follow-up studies of clinical profile and outcomes of this rare disorder are sparse. We studied kidney histopathology baseline findings, outcomes, treatment, and its complications of C3-dominant GN in our setting. Objectives: We studied the clinical, pathological profiles, and outcomes of patients with C3-dominant GN. Methods: This study was a single centre, retrospective, case record based observational study at a tertiary care hospital in Southern India. Consecutive patients of C3-dominant GN on kidney biopsy from 2013 to 2023 were included. Demography, laboratory and histopathological data, treatment and outcomes were studied. Results: Of 2,175 kidney biopsies, 141 (6.48%) showed C3-dominant GN; 74 (52.5%) C3G, 67 (47.5%) IRGN. Median age was 43 years (IQR 29–59.5), males 90 (63.8%). Preceding skin/throat infections were seen in 32/141 (22.7%). At presentation, median serum creatinine was 1.7 mg/dL (IQR: 1.2–3.6), eGFR <60 mL/min/1.73 m2 in 91/141 (64.5%), 111/141 (78.7%) had low serum C3 levels. Nephrotic proteinuria was seen in 65/141 (46%), Crescents in 45 (31.9%). Remission was partial in 38/141 (27%), complete in 45/141 (31.9%) and 31/141 (22%) progressed to end-stage kidney disease (ESKD). On immunosuppression, commonest infection was pneumonia in 15/70 (21.4%) and 27/141 (19.1%) died at an average follow-up of 25.7 months. Diabetes mellitus, percentage sclerosis, and presence of crescents predicted development of CKD stage 5. Conclusion: Over 10 years, C3-dominant GN represented 6.48% of kidney biopsies. Nephrotic proteinuria and kidney failure are common at presentation with 58% achieving some remission, 22% going on to ESKD and mortality of 19%.


  • Open Access

    Role of C4d and CD68 in kidney biopsy as novel prognostic markers for IgA nephropathy; a single-center study from India

    by Pritam Khomane, Ashwin Somwarpet Prabhakar, Shankar Prasad Nagaraju, Indu Ramachandra Rao, Kiran Krishne Gowda, Mahesha Vankalakunti, Ravindra Prabhu Attur, Srinivas Vinayak Shenoy, Dharshan Rangaswamy, Mohan Varadanayakanahalli Bhojaraja, et al.

    Introduction: IgA nephropathy (IgAN) is a common primary glomerulonephritis worldwide. C4d and CD68 could be useful prognostic markers in this disease. Objectives: This study was conducted to assess the clinical and prognostic implications of C4d and CD68 staining in patients with IgAN. Materials and Methods: This is a retrospective single-center observational study. Baseline characteristics and laboratory details were recorded. Renal biopsy was reported according to the MEST-C classification along with further staining for C4d and CD68 by immunohistochemistry. Primary and secondary outcomes were progression to end-stage renal disease (ESRD) and all-cause mortality during follow-up, respectively. The effect of C4d and CD68 along with other risk factors on outcomes was studied. Results: Sixty patients with primary IgAN were analyzed with a median follow-up of 17 months. Forty were males, with a mean age of 39±16 years, and median estimated glomerular filtration rate (eGFR) of 36.5 mL/min/1.73 m2 with a median urine protein/creatinine ratio of 1.9 g/g, at the time of kidney biopsy. In our patients, macroscopic hematuria (n=2: 3.3%) was rare, while 15 (25%) of patients had nephrotic-range proteinuria. Most biopsies showed sclerosis 43 (71.7%) followed by interstitial fibrosis and tubular atrophy (IFTA) 32(53.3%). Meanwhile, crescents were seen in 20 (33.3%). About 39 (65%) of patients had glomerular C4d positivity and 10 (16.7%) had tubulointerstitial CD68 positivity while, none having glomerular CD68 positivity. Glomerular C4d and tubulointerstitial CD68 positivity had lower eGFR, higher proteinuria at presentation (P<0.05) and faster progression to ESRD (glomerular C4d-odds ratio [OR]: 5.7 [95% CI: 1.4-22.5]); tubulointerstitial CD68 OR: 5.4 [ 95% CI: 1.2-23.95]. Other risk factors predicting progression were eGFR at presentation (OR: 0.9 [95% CI: 0.89-0.99], presence of sclerosis OR: 6.5 [95% CI: 1.32-32.06] and IFTA OR: 21.4 [ 95% CI: 4.3-108]). Conclusion: In our study, IgAN patients presented in the later stages of chronic kidney disease, with the majority being diagnosed at stage 3 of this disease. Macroscopic hematuria was rare and nephrotic syndrome and crescents were common. Glomerular C4d and tubulointerstitial CD68 were associated with lower eGFR and more rapid progression.


  • Open Access

    Profiling mortality patterns and place of death in patients on maintenance hemodialysis: a retrospective study in a tertiary care academic hospital in India

    by Surya Gayathri M, Bharathi Naik, Arun Ghoshal, Anuja Damani, Shankar Prasad Nagaraju

    Background: End-stage kidney disease (ESKD) significantly burdens healthcare systems and increases mortality. In India, approximately 175,000 individuals are relying on maintenance hemodialysis (mHD). This study aims to analyze the place of death, mortality patterns and clinical issues surrounding death in patients with ESKD undergoing mHD at a tertiary care hospital in south India. Methods: This retrospective study reviewed the medical records of 280 patients with ESKD who underwent mHD between January 2016 and April 2022. Data were collected on demographics, financial details, comorbidities, cause of death, clinical issues, and location of death. Descriptive statistics, including means, frequencies, and proportions, were used to summarize findings. Results: Among the 280 patients on mHD, there were 98 deaths. Of these, 73.5% died in hospitals, primarily in intensive care units. Of all the patient deaths, 57.7% patients who died at home and 41.6% of hospitalized patients paid out of pocket treatment expenses. Infections and cardiovascular complications were the leading causes of death. High comorbidity and symptom burden were reported, with edema, fatigue, and breathlessness being the most common symptoms. Among the hospital deaths, withholding or withdrawing life sustaining treatments was documented in only 22.2% of cases. Conclusions: Our study provides critical insights into mortality patterns and the need for improved kidney supportive care integration in patients with ESKD. Addressing symptom burden, enhancing ACP, and implementing end of life care protocols could align healthcare delivery with patient preferences, ultimately improving the quality of end of life care in this vulnerable population. Further research is recommended to explore broader interventions and their impact on patient outcomes.


  • Top Cited Papers
    Open Access

    TGF-β: elusive target in diabetic kidney disease

    by Priya Rani, Sindhura Lakshmi Koulmane Laxminarayana, Shilna Muttickal Swaminathan, Shankar Prasad Nagaraju, Mohan Varadanayakanahalli Bhojaraja, Sahana Shetty, Sushma Thimmaiah Kanakalakshmi

    Transforming growth factor-beta (TGF-β), a cytokine with near omnipresence, is an integral part of many vital cellular processes across the human body. The family includes three isoforms: Transforming growth factor-beta 1, 2, and 3. These cytokines play a significant role in the fibrosis cascade. Diabetic kidney disease (DKD), a major complication of diabetes, is increasing in prevalence daily, and the classical diagnosis of diabetes is based on the presence of albuminuria. The occurrence of nonalbuminuric DKD has provided new insight into the pathogenesis of this disease. The emphasis on multifactorial pathways involved in developing DKD has highlighted some markers associated with tissue fibrosis. In diabetic nephropathy, TGF-β is significantly involved in its pathology. Its presence in serum and urine means that it could be a diagnostic tool while its regulation provides potential therapeutic targets. Completely blocking TGF-β signaling could reach untargeted regions and cause unanticipated effects. This paper reviews the basic details of TGF-β as a cytokine, its role in DKD, and updates on research carried out to validate its candidacy.


  • Open Access

    Dialysis in the Elderly: A Practical Guide for the Clinician

    by Aparna Satish, Jhalak Agrohi, Dharshan Rangaswamy, Ravindra Attur Prabhu, Shankar Prasad Nagaraju, Indu Ramachandra Rao, Mohan V. Bhojaraja, Srinivas Vinayak Shenoy

    The increasing prevalence of elderly patients with end‐stage kidney disease (ESKD) poses unique challenges in nephrology. These patients often present with multiple comorbidities, cognitive impairments, and frailty, which significantly impact treatment options and outcomes. Conservative kidney management (CKM) offers a viable alternative to dialysis for many elderly patients by focusing on symptom management and enhancing quality of life rather than merely prolonging life. However, clinicians face difficulties in approaching patients and deciding between CKM and dialysis. In addition, advocating for dialysis involves challenges in selecting the appropriate modality and vascular access. Nutritional management, often overlooked, is critical due to the high prevalence of protein‐energy wasting and sarcopenia among elderly dialysis patients. Similar to the initiation of dialysis, there are dilemmas in determining when to withdraw from dialysis. This practical review aims to guide clinicians through the complex and challenging process of managing dialysis in the elderly, emphasizing a holistic, patient‐centered approach that prioritizes quality of life. A multidisciplinary strategy, integrating clinical expertise and patient autonomy, is essential to address the complex needs of this vulnerable population.


  • Open Access

    The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review

    by Shankar Prasad Nagaraju, Shilna Muttickal Swaminathan, Priya Rani, Indu Ramachandra Rao, Ravindra Prabhu Attur, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Ankur Gupta, Mohan V Bhojaraja

    Lupus nephritis (LN) is a major organ condition in systemic lupus erythematosus (SLE) leading to end-stage kidney disease if not managed effectively. Two main therapeutic approaches that are successful in the management of LN include immunosuppression and non-immunosuppressive drugs, renin-angiotensin-aldosterone system inhibitors, and hydroxychloroquine (HCQ), which are supported by numerous clinical trials. Recent clinical trials with sodium-glucose cotransporter-2 inhibitors (SGLT2i) have consistently shown substantial evidence of reno-protection for those with IgA nephropathy and focal segmental glomerulosclerosis. However, emerging evidence shows the protective role of SGLT2i in renal outcomes for the management of LN. This review explores the underlying mechanisms by which SGLT2i contributes to nephroprotection, with promising evidence from both animal and human studies, and guideline recommendations regarding its utilization in LN.

  • Open Access

    Outcomes of arteriovenous fistula and role of duplex ultrasound for its assessment in pre-dialysis patients; a single center longitudinal study

    by Bendalam Gouthami, Shankar Prasad Nagaraju, Shilna Muttickal Swaminathan, Divya Datta, Ravindra Prabhu Attur, Indu Ramachandra Rao, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Mohan V Bhojaraja

    Introduction: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis; however, it has a primary failure rate of 20%–60%. Analyzing the factors associated with AVF failure is crucial for planning appropriate management strategies. Objectives: We aimed to identify the AVF outcomes and associated factors along with the role of duplex ultrasound (DUS) in preoperative and postoperative AVF assessment at a tertiary care hospital. Patients and Methods: This prospective observational study was conducted on pre-dialysis patients who underwent AVF creation between January 2020 and December 2021.AVF outcomes and associated clinical and vascular factors were analyzed using pre- and post-operative DUS. Results: Of 171 patients, males were predominant (83.6%), and diabetic nephropathy (42.7%) was the predominant cause of chronic kidney disease (CKD). AVF outcomes showed, 109 (63.7%) had unassisted mature AVF and 29 (16.9%) had AVF failure wherein early dialysis suitability failure was predominant (17; 9.94%). Among clinical factors, only a history of smoking correlated with AVF failure (P=0.04). On pre-and post-operative DUS assessment, the absence of distensibility and immediate post-operative vein diameter strongly correlated with AVF failure (P<0.001). A unit increase (1 mm) in outflow vein diameter immediately after surgery emerged as an independent predictor of AVF outcome in both univariate (OR 0.98, 95% CI: 0.35-3.99; P<0.001) and multivariate analysis (OR: 0.313, 95% CI: 0.148-0.663; P<0.001). Conclusion: Most patients in our setting had unassisted AVF fistula. We additionally found that smoking correlated with AVF failure. Predominant factors determining AVF success were cephalic vein diameter, distensibility, and increase in draining vein diameter and flow volume at six weeks. This study highlights using DUS in pre- and post-operative periods, along with conventional examination to improve AVF outcomes.

  • Open Access

    Octogenarians on dialysis; navigating survival amidst struggles

    by Jhalak Agrohi, Saksham Kohli, Srinivas Vinayak Shenoy, Daksh Agrohi, Shankar Prasad Nagaraju, Attur Ravindra Prabhu, Dharshan Rangaswamy, Indu Ramachandra Rao, Mohan Varadanayakanahalli Bhojaraja

    Introduction: The escalating longevity facilitated by medical advancements has led to a surge in elderly individuals grappling with chronic kidney disease (CKD) and progressing to end-stage renal disease (ESRD). Objectives: Our study addresses the paucity of research on octogenarians undergoing dialysis, a highly co-morbid and frail subset, particularly in the context of a resource-limited setting like India. Patients and Methods: A retrospective observational study at Kasturba Medical College and Hospital in Manipal, India, examined 18 octogenarian dialysis patients from 2017 to 2022. Clinical details, including age, co-morbidities, dialysis patterns, and laboratory data, were collected. The Cox-proportional hazards model assessed factors influencing survival. Results: The majority-initiated dialysis in emergencies (72%), predominantly via central venous catheters. Hospitalizations post-dialysis were common (median 2.5). Survival rates at 1, 3, and 5 years were 61%, 54%, and 44%, respectively. Sudden cardiac death (64%) emerged as the predominant cause, with a significant impact of a higher Charlson comorbidity index on survival (HR 3.11; 95% CI [1.21-7.89]; P = 0.018). Conclusion: Octogenarian dialysis patients, marked by substantial co-morbidities, exhibit reduced survival, particularly with higher comorbidity scores. Hospitalizations contribute significantly to morbidity. Our study underscores the need for nuanced care strategies tailored to this vulnerable population.

  • Open Access

    Post kidney transplant hematologic abnormalities and association of post-transplant anemia with graft function

    by Sindhura Lakshmi Koulmane Laxminarayana, Shreya Jayaram, Shilna Muttickal Swaminathan, Ravindra Prabhu Attur, Dharshan Rangaswamy, Indu Ramachandra Rao, Mohan V Bhojaraja, Srinivas Vinayak Shenoy, Shankar Prasad Nagaraju

    Background Haematological abnormalities following renal transplantation are frequently observed and have a significant effect on survival and graft outcomes. The pattern of haematological abnormalities varies globally. Few studies have been conducted in Asian countries. We aimed to evaluate the patterns of haematological abnormalities in post-transplant recipients in our center during the first year after post-renal transplant and the association of post-transplant anemia with graft function. Methods This single-center retrospective study was conducted on renal transplantation recipients between 2014 and 2019. The study included all patients who received kidney transplants from live/cadaveric donors and had follow-up data collected up to 12 months after the transplant. The outcome studied was the prevalence of haematological abnormalities and the association between post-transplant anemia (PTA) and graft function in post-transplant recipients. Results A total of 106 renal transplant recipients were included in the study. The prevalence of PTA was 98% in the first week, 75% at one month, 35% at three months, 32% at six months, and 27% at 12 months. The other cytopenia cases were leukopenia (43.4%), thrombocytopenia (33.2%), and pancytopenia (15.1%). Post-transplant erythrocytosis was observed in 17.9% of patients. 18 patients with severe PTA in the first week of transplant had significant allograft dysfunction (p=0.04). Patients with and without PTA had similar graft functions at six and 12 months (p=0.50). Conclusions Haematological abnormalities are common in renal transplant recipients. PTA is highly prevalent during the first week and improves over time. Other haematological abnormalities observed were leukopenia, thrombocytopenia, pancytopenia, and post-transplant erythrocytosis. Leucopenia was primarily drug-induced, and thrombocytopenia and pancytopenia were frequently caused by infections in our cohort. Additionally, severe PTA was significantly associated with graft dysfunction in the first week post-transplant, whereas similar graft function was observed at 6 and 12 months post-transplant, irrespective of the presence or absence of PTA.